Popular Arthritis Drug For Dogs May Have Severe Side Effects, F.D.A. Says
The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse reactions.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.